Aarhus University Seal

5 mio DKK from the Lundbeck Foundation to test potential treatment of Covid-19 patients

Mads Fuglsang Kjølby, affiliated Anders Nykjær's lab at DANDRITE/PROMEMO, and Ole Schmeltz Søgaard, will test the effect of Camostat Mesylate on SARS-CoV-2 infections in Covid-19 patients.

Mads Fuglsang Kjølby. Photo: Tonny Foghmar, AUH

Associate professor and MD, PhD, Mads Fuglsang Kjølby from Department of Biomedicine, Aarhus University, and Department of Clinical Pharmacology, Aarhus University Hospital, and Associate professor and MD, PhD Ole Schmeltz Søgaard from Department of Clinical Medicine, Aarhus University, and Department of Infectious Diseases, Aarhus University Hospital, were interviewed about the upcoming clinical trial by TV2 (link to interview

Read more about the researchers and the clinical trial here (health.au.dk).